A dynamic role of HAUSP in the p53-Mdm2 pathway

Molecular Cell

Volumn 13, Issue 6, 2004, Pages 879-886

  Li, Muyang ^a   Brooks, Christopher L ^a   Kon, Ning ^a   Gu, Wei ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MDM2; PROTEIN P53; UBIQUITIN THIOLESTERASE;

ARTICLE; CONTROLLED STUDY; FEMALE; HELA CELL; HUMAN; HUMAN CELL; OSTEOSARCOMA; OSTEOSARCOMA CELL; REGULATORY MECHANISM; UBIQUITINATION;

BONE NEOPLASMS; CELL LINE, TUMOR; DRUG STABILITY; ENDOPEPTIDASES; HELA CELLS; HUMANS; MICRORNAS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 1842421376     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(04)00157-1     Document Type: Article

References (34)

1. Ashcroft M., Vousden K.H. Regulation of p53 stability. Oncogene. 18:1999;7637-7643.
2. Brooks C.L., Gu W. Ubiquitination, phosphorylation and acetylation. the molecular basis for p53 regulation Curr. Opin. Cell Biol. 15:2003;164-171.
3. D'Andrea A., Pellman D. Deubiquitinating enzymes. a new class of biological regulators Crit. Rev. Biochem. Mol. Biol. 33:1998;337-352.
4. Everett R.D., Meredith M., Orr A., Cross A., Kathoria M., Parkinson J. A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J. 16:1997;1519-1530.
5. Finch R.A., Donoviel D.B., Potter D., Shi M., Fan A., Freed D.D., Wang C.Y., Zambrowicz B.P., Ramirez-Solis R., Sands A.T.et al. mdmx is a negative regulator of p53 activity in vivo. Cancer Res. 62:2002;3221-3225.
6. Freedman D.A., Wu L., Levine A.J. Functions of the MDM2 oncoprotein. Cell. Mol. Life Sci. 55:1999;96-107.
7. Gu J., Kawai H., Nie L., Kitao H., Wiederschain D., Jochemsen A.G., Parant J., Lozano G., Yuan Z.M. Mutual dependence of MDM2 and MDMX in their functional inactivation of p53. J. Biol. Chem. 277:2002;19251-19254.
8. Haupt Y., Maya R., Kazaz A., Oren M. Mdm2 promotes the rapid degradation of p53. Nature. 387:1997;296-299.
9. Hemann M.T., Fridman J.S., Zilfou J.T., Hernando E., Paddison P.J., Cordon-Cardo C., Hannon G.J., Lowe S.W. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat. Genet. 33:2003;396-400.
10. Hengstermann A., Linares L.K., Ciechanover A., Whitaker N.J., Scheffner M. Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells. Proc. Natl. Acad. Sci. USA. 98:2001;1218-1223.
11. Hicke L., Dunn R. Regulation of membrane protein transport by ubiquitin and ubiquitin-binding proteins. Annu. Rev. Cell Dev. Biol. 19:2003;141-172.
12. Holowaty M.N., Sheng Y., Nguyen T., Arrowsmith C., Frappier L. Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP. J. Biol. Chem. 278:2003;47753-47761. a.
13. Holowaty M.N., Zeghouf M., Wu H., Tellam J., Athanasopoulos V., Greenblatt J., Frappier L. Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7. J. Biol. Chem. 278:2003;29987-29994. b.
14. Honda R., Tanaka H., Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420:1997;25-27.
15. Hu M., Li P., Li M., Li W., Yao T., Wu J.W., Gu W., Cohen R.E., Shi Y. Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell. 111:2002;1041-1054.
16. Jones S.N., Roe A.E., Donehower L.A., Bradley A. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature. 378:1995;206-208.
17. Kamijo T., Zindy F., Roussel M.F., Quelle D.E., Downing J.R., Ashmun R.A., Grosveld G., Sherr C.J. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell. 91:1997;649-659.
18. Kubbutat M.H., Jones S.N., Vousden K.H. Regulation of p53 stability by Mdm2. Nature. 387:1997;299-303.
19. Li M., Chen D., Shiloh A., Luo J., Nikolaev A.Y., Qin J., Gu W. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature. 416:2002;648-653.
20. Li M., Brooks C.L., Wu-Baer F., Chen D., Baer R., Gu W. Mono- versus polyubiquitination. differential control of p53 fate by Mdm2 Science. 302:2003;1972-1975.
21. Lim S.K., Shin J.M., Kim Y.S., Baek K.H. Identification and characterization of murine mHAUSP encoding a deubiquitinating enzyme that regulates the status of p53 ubiquitination. Int. J. Oncol. 24:2004;357-364.
22. Linares L.K., Hengstermann A., Ciechanover A., Muller S., Scheffner M. HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53. Proc. Natl. Acad. Sci. USA. 100:2003;12009-12014.
23. Lowe S.W., Sherr C.J. Tumor suppression by Ink4a-Arf. progress and puzzles Curr. Opin. Genet. Dev. 13:2003;77-83.
24. Michael D., Oren M. The p53-Mdm2 module and the ubiquitin system. Semin. Cancer Biol. 13:2003;49-58.
25. Migliorini D., Denchi E.L., Danovi D., Jochemsen A., Capillo M., Gobbi A., Helin K., Pelicci P.G., Marine J.C. Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development. Mol. Cell. Biol. 22:2002;5527-5538.
26. Montes de Oca Luna R., Wagner D.S., Lozano G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature. 378:1995;203-206.
27. Munger K., Howley P.M. Human papillomavirus immortalization and transformation functions. Virus Res. 89:2002;213-228.
28. Parant J., Chavez-Reyes A., Little N.A., Yan W., Reinke V., Jochemsen A.G., Lozano G. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53. Nat. Genet. 29:2001;92-95.
29. Sherr C.J. The INK4a/ARF network in tumour suppression. Nat. Rev. Mol. Cell Biol. 2:2001;731-737.
30. Stad R., Little N.A., Xirodimas D.P., Frenk R., van der Eb A.J., Lane D.P., Saville M.K., Jochemsen A.G. Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms. EMBO Rep. 2:2001;1029-1034.
31. Stott F.J., Bates S., James M.C., McConnell B.B., Starborg M., Brookes S., Palmero I., Ryan K., Hara E., Vousden K.H.et al. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17:1998;5001-5014.
32. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature. 408:2000;307-310.
33. Wilkinson K.D. Signal transduction. aspirin, ubiquitin and cancer Nature. 424:2003;738-739.
34. Zhang Y., Xiong Y. Control of p53 ubiquitination and nuclear export by MDM2 and ARF. Cell Growth Differ. 12:2001;175-186.